Evercore Inc. (EVR) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Evercore Inc. (EVR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

265.50

4.64 (1.78%)

At close: Jan 14, 2025, 3:59 PM

267.50

0.75%

Pre-market Jan 15, 2025, 08:06 AM EST

undefined% (undefined)

Bid	266.68
Market Cap	10.11B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	7.75
PE Ratio (ttm)	34.26
Forward PE	n/a
Analyst	Hold

Ask	278.05
Volume	420,391
Avg. Volume (20D)	360,801
Open	267.43
Previous Close	260.86
Day's Range	261.56 - 267.43
52-Week Range	165.07 - 324.06
Beta	undefined

About EVR

Evercore Inc., together with its subsidiaries, operates as an independent investment banking advisory firm in the United States, Europe, Latin America, and internationally. It operates through two segments, Investment Banking and Investment Management. The Investment Banking segment offers strategic advisory services, such as mergers and acquisitions, strategic, defense, and shareholder advisory, special committee assignments, and transaction str...

[Show more]

Industry Financial - Capital Markets

Sector Financial Services

IPO Date Aug 14, 2006

Employees 2,395

Stock Exchange NYSE

Ticker Symbol EVR

Website https://www.evercore.com

Analyst Forecast

According to 6 analyst ratings, the average rating for EVR stock is "Hold." The 12-month stock price forecast is $305, which is an increase of 14.88% from the latest price.

Buy 33.33%

Hold 66.67%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Evercore Inc. is scheduled to release its earnings on Jan 29, 2025, before market opens.
Analysts project revenue of $883.40M, reflecting a 11.78% YoY growth and earnings per share of 2.83, making a 40.10% increase YoY.

Why Price Moved

3 weeks ago · Source

-6.1%

Shares of financial companies are trading lower am... Unlock content with Pro Subscription

3 months ago · Source

+5.03%

Shares of banking and financial services stocks are trading higher following better-than-expected financial results from JPMorgan Chase and Wells Fargo.

News

1 week ago · youtube.com

Meta won't see material impact from tossing fact checking, says Evercore ISI's Mark Mahaney

Mark Mahaney, Evercore ISI head of internet research, joins 'Closing Bell Overtime' to talk announcements from Meta on changes to its moderation process.

1 week ago · seekingalpha.com

Trump Win Meaningful For Large Ticket Deals, We Like Evercore Over Moelis

Trump's victory should be considered when looking at companies with exposure to large ticket transactions like EVR, since a laxer FTC will have a positive bearing on those markets. We do want to point...

1 week ago · businesswire.com

Evercore ISI to Host 11th Annual Utility CEO Conference, Jan. 8-10, 2025

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) will host its 11th annual Utility CEO Conference in Scottsdale, Arizona, Jan. 8-10, 2025. The power & utilities sector is rapidly establishing itself as...

1 week ago · zacks.com

Evercore Thrives on Improving M&A Trend Amid Escalating Costs

EVR's rising IB business revenues and strong balance sheet position look encouraging. Yet, rising costs are concerning.

2 weeks ago · youtube.com

Evercore's Roger Altman reflects on Jimmy Carter's legacy

Roger Altman, Evercore senior chairman and former assistant treasury secretary in the Carter Administration, reflects on the life and legacy of Jimmy Carter.

2 weeks ago · youtube.com

Evercore ISI's Mark Mahaney on why he is long Uber

Mark Mahaney, Evercore ISI, joins 'Closing Bell Overtime' to talk his investing playbook for Uber.

3 weeks ago · youtube.com

Evercore ISI's Jonathan Chappell breaks down FedEx earnings, company separation and outlook

Jonathan Chappell, Evercore ISI Senior Managing Director, joins 'Closing Bell: Overtime' to discuss FedEx earnings, company separation and outlook.

4 weeks ago · https://thefly.com

PPG price target lowered to $145 from $152 at Evercore ISI

Evercore ISI lowered the firm's price target on PPG to $145 from $152 and keeps an In Line rating on the shares as a new analyst took over coverage of the stock and 10 other chemical names. Dissonance...

4 weeks ago · https://thefly.com

LyondellBasell price target lowered to $90 from $110 at Evercore ISI

Evercore ISI lowered the firm's price target on LyondellBasell to $90 from $110 and keeps an In Line rating on the shares as a new analyst took over coverage of the stock and 10 other chemical names. ...

4 weeks ago · https://thefly.com

Linde price target raised to $490 from $465 at Evercore ISI

Evercore ISI analyst Eric Boyes raised the firm's price target on Linde to $490 from $465 and keeps an Outperform rating on the shares as a new analyst took over coverage of the stock and 10 other che...

4 weeks ago · https://thefly.com

Eastman Chemical transferred with an In Line at Evercore ISI

Evercore ISI took over coverage of Eastman Chemical with an In Line rating and $118 price target as well as 10 other chemical names. Dissonance between sputtering industrial demand into year-end and p...

4 weeks ago · https://thefly.com

Ecolab price target raised to $265 from $250 at Evercore ISI

Evercore ISI raised the firm's price target on Ecolab to $265 from $250 and keeps an In Line rating on the shares as a new analyst took over coverage of the stock and 10 other chemical names. Dissonan...

4 weeks ago · https://thefly.com

Celanese price target lowered to $85 from $170 at Evercore ISI

Evercore ISI analyst Eric Boyes lowered the firm's price target on Celanese to $85 from $170 and keeps an In Line rating on the shares as a new analyst took over coverage of the stock and 10 other che...

4 weeks ago · https://thefly.com

AZZ Inc. transferred with an Outperform at Evercore ISI

Evercore ISI took over coverage of AZZ Inc. with an Outperform rating and $90 price target as well as 10 other chemical names. Dissonance between sputtering industrial demand into year-end and prospec...

4 weeks ago · https://thefly.com

Axalta Coating transferred with an Outperform at Evercore ISI

Evercore ISI took over coverage of Axalta Coating with an Outperform rating and $47 price target as well as 10 other chemical names. Dissonance between sputtering industrial demand into year-end and p...

4 weeks ago · https://thefly.com

Ashland price target lowered to $85 from $100 at Evercore ISI

Evercore ISI analyst Eric Boyes lowered the firm's price target on Ashland to $85 from $100 and keeps an In Line rating on the shares as a new analyst took over coverage of the stock and 10 other chem...

4 weeks ago · https://thefly.com

Air Products price target raised to $375 from $365 at Evercore ISI

Evercore ISI raised the firm's price target on Air Products to $375 from $365 and keeps an Outperform rating on the shares as a new analyst took over coverage of the stock and 10 other chemical names....

4 weeks ago · https://thefly.com

Evercore says Dow Inc. 'on the brink of better,' upgrades to Outperform

Evercore ISI analyst Eric Boyes upgraded Dow Inc. to Outperform from In Line with a $56 price target as a new analyst took over coverage of the stock and 10 other chemical names. Double-digit 2025 EBI...

4 weeks ago · https://thefly.com

Dow Inc. upgraded to Outperform from In Line at Evercore ISI

Evercore ISI upgraded Dow Inc. to Outperform from In Line.

1 month ago · businesswire.com

Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl...

Load More News